Protein_Domain

Part:BBa_K4839008

Designed by: Xuming Zeng   Group: iGEM23_SYSU-SLS-CHINA   (2023-10-03)
Revision as of 11:53, 12 October 2023 by Indigo30 (Talk | contribs)


IRF4 Binding protein

Our modeling work also contribute to our part collection. In order to directly target to the IRF4 protein (Figure 1.), we synthesis an IRF4 binding protein through modeling. The detailed process of our modeling work can be found on the model page.


Figure1. The function of anti-IRF4 BioPROTAC

With the help of computer modeling including molecular dynamics, we succeedly synthesis the Anti-IRF4 protein, which is called IRF4 binding protein here. The IRF4 binding protein can specifically binds to the IRF4 protein, and thus the BioPROTAC will trigger the degradation of the IRF4 and furher lead to the changing of the phenotype of the macrophage.


With the help of computer modeling including molecular dynamics, we succeedly synthesis the Anti-IRF4 protein, which is called IRF4 binding protein here. The IRF4 binding protein can specifically binds to the IRF4 protein, and thus the BioPROTAC will trigger the degradation of the IRF4 and furher lead to the changing of the phenotype of the macrophage.

We have successfully constructed the IRF4 Binding protein (anti-IRF4 BioPROTAC) and assembled it into the pLVX-TREG3S-FLAG-TetOne-Puro vector regulated by doxycycline-controlled Tet-on system. We have also completed the construction of pLVX-TREG3S-FLAG-PU.1-(SSG)3-SPOP-TetOne-Puro and the sequencing results are shown in Figure 2.

Figure2. Sequencing results confirm the successful construction of IRF4 Binding protein (PU.1-SPOP).


We have performed structure simulation using Alphafold and conducted molecular docking using our pipeline. The results are shown in Figure 3.

Figure 3. The interface between PU.1 and IRF4

[1] Lim S , Khoo R , Peh K M ,et al.bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)[J].Proceedings of the National Academy of Sciences, 2020(11).DOI:10.1073/PNAS.1920251117.

[2] Békés, M., Langley, D.R. & Crews, C.M. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 21, 181–200 (2022). https://doi.org/10.1038/s41573-021-00371-6

Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 271
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 271
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 271
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 271
    Illegal AgeI site found at 548
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None